A thought-provoking article in The Daily Telegraph about the costs (emotional and financial) of cancer treatment versus the results – often as little as a few additional weeks of life for millions of dollars worth of drugs.  What should be the next step for clinicians, scientists, pharmaceutical companies, regulators and others involved in this type of care?